Telemedicine pioneer's quality resources and services are recognized by recent recertification FORT MYERS, Fla., Sept. 17, 2024 /PRNewswire/ -- TeleSpecialists,…
Preliminary immunogenicity results demonstrate induction of cancer antigen-specific T-cell responses in 77% of evaluable patients following CVGBM monotherapy84% of immune…
Marks first EMA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and…
Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE,…
LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)…
PARAMUS, N.J., Sept. 10, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon…
A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and…
LIBERTYVILLE, Ill.--(BUSINESS WIRE)--#SaMD--JuneBrain is excited to announce our selection to receive a grant award from the Medical Device Innovation Consortium’s…
DENVER, Sept. 5, 2024 /PRNewswire/ -- Exer AI, a clinical AI company addressing musculoskeletal (MSK) and movement disorders, today announced a…
NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…